01 August 2004
Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis
Dina R. Ivanen, Anna A. Kulminskaya, Konstantin A. Shabalin, Luydmila V. Isaeva-Ivanova, Nadezhda A. Ershova, Andrew N. Saveliev, Gregory A. Nevinsky, Kirill N. NeustroevMed Sci Monit 2004; 10(8): BR273-280 :: ID: 11725
Abstract
Background:Recently, amylolytic activity was detected in IgMs isolated from the sera of the patients with multiple sclerosis.Material/Methods: All purified samples of IgM were electrophoretically homogenous and did not contain any co-purified α-amylase and α-glucosidase activities, in accordance with a set of criteria developed for abzymes. The amylolytic activity of abzymes was studied in the hydrolysis of p-nitrophenyl α-D-maltooligosaccharides with different degrees of polymerization from 1 to 8 by TLC and reverse-phase HPLC techniques.Results: All IgM samples isolated from 54 patients with clinically definite multiple sclerosis demonstrated hydrolytic activity towards the above artificial substrates. The Michaelis constant values (Km) in the hydrolysis of p-nitrophenyl α-D-maltoheptaoside were in the range of 10 p-nitrophenyl or p-nitrophenyl α-D-glucosides, thus indicating the presence of an α-D-glucosidase activity. For a number of the investigated samples, specific amylolytic activity increased depending on the length of substrates (from p-nitrophenyl maltopentaoside to p-nitrophenyl maltohexaoside); for other IgMs, the opposite dependence was observed. All IgMs studied did not exhibit any other glycoside hydrolase activities toward p-nitrophenyl glycoside substrates.Conclusions: Abzyme fractions from different donors demonstrated catalytic heterogeneity in Michaelis-Menten parameters and different modes of action in the hydrolysis of p-nitrophenyl maltooligosaccharides. Enzymatic properties of the IgMs tested varied from human a-amylases. All investigated abzyme samples did not show transglycosylating ability.
Keywords: Nitrobenzenes - chemistry, Amylases - metabolism, Antibodies, Catalytic - blood, Chromatography, High Pressure Liquid, Immunoglobulin M - metabolism, Multiple Sclerosis - enzymology, Nitrobenzenes - chemistry, Oligosaccharides - chemistry
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Clinical Research
Iliac Periosteal Bone Autografting vs Talus Non-Weight-Bearing Surgery in Hepple V Talus Osteochondral Inju...Med Sci Monit In Press; DOI: 10.12659/MSM.944912
Clinical Research
Impact of Different Orthodontic Appliances on Mandibular Condyle, Anterior Region of Mandibular, and Maxill...Med Sci Monit In Press; DOI: 10.12659/MSM.946265
Clinical Research
Risk Factors for Bone Cement Displacement After Percutaneous Kyphoplasty in Osteoporotic Vertebral Fracture...Med Sci Monit In Press; DOI: 10.12659/MSM.945884
Clinical Research
Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Acti...Med Sci Monit In Press; DOI: 10.12659/MSM.945273
Most Viewed Current Articles
17 Jan 2024 : Review article 6,407,835
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,909,112
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,529
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 260,637
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074